{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-011461","form_type":"8-K","ticker":null,"cik":"0001261249","company_name":"AGILE THERAPEUTICS INC","filed_at":"2023-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.216226+00:00","generated_at":"2026-06-13T16:02:59.596638+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Agile Therapeutics appoints Scott Coiante as SVP, CFO; CAO Jason Butch to depart","bullets":["Scott Coiante appointed SVP, CFO and Treasurer effective Aug 16, 2023; he previously served as Agile's CFO from 2010-2019.","Jason Butch to separate as Chief Accounting Officer on Aug 15, 2023 by mutual agreement.","Butch to receive 6 months base salary and health care subsidies as severance, subject to signing release.","Coiante most recently CFO of Aprea Therapeutics; prior roles at Medarex and Ernst & Young.","No family relationships or material interests between Coiante and any director or officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-011461","json":"https://secwatch.observer/filing/0001558370-23-011461.json","markdown":"https://secwatch.observer/filing/0001558370-23-011461.md","text":"https://secwatch.observer/filing/0001558370-23-011461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/0001558370-23-011461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/agrx-20230621x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T16:02:59.596638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"509bd60f98","claim":"Jason Butch departed as Chief Accounting Officer at AGILE THERAPEUTICS INC.","evidence_excerpt":"the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch will separate from service as the Chief Accounting Officer, effective August 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/0001558370-23-011461-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separate from service"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"e476a77ac5","claim":"Scott Coiante was appointed as Senior Vice President, Chief Financial Officer and Treasurer at AGILE THERAPEUTICS INC.","evidence_excerpt":"the Board of Directors of Agile Therapeutics, Inc. (the “Company”) appointed Scott Coiante to serve as Senior Vice President. Chief Financial Officer and Treasurer, effective August 16, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/0001558370-23-011461-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}